NCT07065578

Brief Summary

The aim of this study is optimize the STAR (SympTom mAnagement self-caRe) intervention to support patients with HF in staying healthy, and particularly in self-monitoring and managing symptoms. The STAR intervention includes promising components aiming at improving patient outcomes in terms of interference of bothersome symptoms, self-care, quality of life (QoL) and healthcare utilization. In this study, the intervention components are tested in an optimization trial in 320 patients with HF from 8 HF clinics in the Netherlands. This study will result in an optimized STAR intervention, composed of the best components, that is effective, scalable, and efficient to improve patient outcomes and can be used in HF clinics.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
320

participants targeted

Target at P75+ for not_applicable

Timeline
11mo left

Started Jul 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Jul 2025Mar 2027

First Submitted

Initial submission to the registry

June 19, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 15, 2025

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Last Updated

July 15, 2025

Status Verified

July 1, 2025

Enrollment Period

1.7 years

First QC Date

June 19, 2025

Last Update Submit

July 3, 2025

Conditions

Keywords

Heart FailureSelf-managementsymptom managementSelf-caree-Health

Outcome Measures

Primary Outcomes (1)

  • Interference of bothersome symptoms

    For interference of bothersome symptoms three domains of the Kansas City Cardiomyopathy Questionnaire will be assessed: symptom, physical function and symptom stability. Scores are standardized on a scale from 0 to 100, with higher scores representing fewer symptoms.

    From Baseline (T0) to the end of the last module (T4) at the following time points: Baseline (T0), week 1 (T1), week 2-3 (T2), week 4 (T3), week 6 (T4)

Secondary Outcomes (5)

  • Self-care

    Measured at baseline and week 6 (T4)

  • HRQoL

    Measured at baseline and week 6 (T4)

  • Healthcare utilization

    Measured at baseline and week 6 (T4)

  • Healthcare utilization 2

    Measured at baseline and week 6 (T4)

  • Healthcare utilization 3

    Measured at baseline and week 6 (T4)

Other Outcomes (9)

  • Illness perceptions

    Measured at week 1 (T1) and week 2-3 (T2 )

  • HF knowledge

    Measured at baseline and week 1 (T1)

  • Interoception

    Measured at baseline, week 1(T1), week 2-3 (T2), week 6 (T4)

  • +6 more other outcomes

Study Arms (8)

Condition 1

EXPERIMENTAL

Module 1: Low version; Module 2: Low version; Module 3: Low version

Other: STAR condition 1

Condition 2

EXPERIMENTAL

Module 1: Low version; Module 2: Low version; Module 3: High version

Other: STAR condition 2

Condition 3

EXPERIMENTAL

Module 1: Low version; Module 2: High version; Module 3: High version

Other: STAR condition 3

Condition 4

EXPERIMENTAL

Module 1: Low version; Module 2: High version; Module 3: Low version

Other: STAR condition 4

Condition 5

EXPERIMENTAL

Module 1: High version; Module 2: Low version; Module 3: Low version

Other: STAR condition 5

Condition 6

EXPERIMENTAL

Module 1: High version; Module 2: Low version; Module 3: High version

Other: STAR condition 6

Condition 7

EXPERIMENTAL

Module 1: High version; Module 2: High version; Module 3: Low version

Other: STAR condition 7

Condition 8

EXPERIMENTAL

Module 1: High version; Module 2: High version; Module 3: High version

Other: STAR condition 8

Interventions

* Basic module: HF information and doing symptom awareness exercises. * Low version Module 1: Symptom awareness exercises 2 times in 1 week, and written feedback HF nurse * Low version Module 2: Coaching in symptom management response and choose symptom response option to experiment with. Written feedback from HF nurse * Low version Module 3: Instruction and doing symptom management experiments for 2 weeks + keep logs; Written feedback HF nurse

Condition 1

Basic module: aims to improve the participant's illness perceptions and standardize HF knowledge at the start of the intervention and doing exercises.- Low version Module 1: Symptom awareness exercises 2 times in 1 week, and written feedback HF nurse - Low version Module 2: Coaching in symptom management response and choose symptom response option to experiment with. Written feedback from HF nurse - High version Module 3: Instruction and doing symptom management experiments for 2 weeks + keep logs; Verbal feedback HF nurse

Condition 2

Basic module: aims to improve the participant's illness perceptions and standardize HF knowledge at the start of the intervention and doing exercises.- Low version Module 1: Symptom awareness exercises 2 times in 1 week, and written feedback HF nurse - High version Module 2: Coaching in symptom management response and choose symptom response option to experiment with. Verbal feedback from HF nurse - High version Module 3: Instruction and doing symptom management experiments for 2 weeks + keep logs; Verbal feedback HF nurse

Condition 3

Basic module: aims to improve the participant's illness perceptions and standardize HF knowledge at the start of the intervention and doing exercises.- Low version Module 1: Symptom awareness exercises 2 times in 1 week, and written feedback HF nurse - High version Module 2: Coaching in symptom management response and choose symptom response option to experiment with. Verbal feedback from HF nurse - Low version Module 3: Instruction and doing symptom management experiments for 2 weeks + keep logs; Written feedback HF nurse

Condition 4

Basic module: aims to improve the participant's illness perceptions and standardize HF knowledge at the start of the intervention and doing exercises.- High version Module 1: Symptom awareness exercises 6 times in 2 weeks, and verbal feedback HF nurse - Low version Module 2: Coaching in symptom management response and choose symptom response option to experiment with. Written feedback from HF nurse - Low version Module 3: Instruction and doing symptom management experiments for 2 weeks + keep logs; written feedback HF nurse

Condition 5

Basic module: aims to improve the participant's illness perceptions and standardize HF knowledge at the start of the intervention and doing exercises.- High version Module 1: Symptom awareness exercises 6 times in 2 weeks, and verbal feedback HF nurse - Low version Module 2: Coaching in symptom management response and choose symptom response option to experiment with. Written feedback from HF nurse - High version Module 3: Instruction and doing symptom management experiments for 2 weeks + keep logs; Verbal feedback HF nurse

Condition 6

Basic module: aims to improve the participant's illness perceptions and standardize HF knowledge at the start of the intervention and doing exercises.- High version Module 1: Symptom awareness exercises 6 times in 2 weeks, and verbal feedback HF nurse - High version Module 2: Coaching in symptom management response and choose symptom response option to experiment with. Verbal feedback from HF nurse - Low version Module 3: Instruction and doing symptom management experiments for 2 weeks + keep logs; Written feedback HF nurse

Condition 7

Basic module: aims to improve the participant's illness perceptions and standardize HF knowledge at the start of the intervention and doing exercises.- High version Module 1: Symptom awareness exercises 6 times in 2 weeks, and verbal feedback HF nurse - High version Module 2: Coaching in symptom management response and choose symptom response option to experiment with. Verbal feedback from HF nurse - High version Module 3: Instruction and doing symptom management experiments for 2 weeks + keep logs; Verbal feedback HF nurse

Condition 8

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with HF (irrespective of ejection fraction) and symptomatic NYHA class II or III.
  • years or older.
  • Willing and able to provide written informed consent.
  • Life expectancy \>6 months.
  • Optimal medical HF treatment following ESC HF guidelines (i.e. 'patients with stable HF').

You may not qualify if:

  • Participants living in a care facility (e.g. nursing home, revalidation center).
  • Language barrier preventing sufficient understanding and communication in Dutch.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Heleen Westland, PhD

    UMC Utrecht

    PRINCIPAL INVESTIGATOR
  • Tiny Jaarsma, PhD

    UMC Utrecht and Linköping University

    STUDY CHAIR

Central Study Contacts

Michelle van Rijn, MSc

CONTACT

Heleen Westland, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
FACTORIAL
Model Details: This study has a randomized factorial experimental design with 2\^3 = 8 experimental conditions to examine the effects of the three individual key modules. With this design, the main effects of each module and the interaction between modules will be tested. After informed consent, participants will be randomized using stratified block randomization to one of the eight experimental conditions within each participating HF clinic.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

June 19, 2025

First Posted

July 15, 2025

Study Start

July 1, 2025

Primary Completion (Estimated)

March 31, 2027

Study Completion (Estimated)

March 31, 2027

Last Updated

July 15, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Interested parties can request access to this data-set via our institutional data access committee (DC) for the EGA; based on the assessment of the DAC access to this data-set will be granted or declined.